Literature DB >> 108901

Auditory involvement in thalassemia major.

S De Virgiliis, F Argiolu, G Sanna, G Cornacchia, P Cossu, A Cao, V Mallardi, P Puxeddu.   

Abstract

The auditory function of 75 children affected by homozygous beta0-thalassemia, managed with a low transfusion scheme and treated irregularly with low doses of desferrioxamine, and of 75 controls were examined. In 12 patients a mild bilateral conductive hearing impairment due to bony hypertrophy and/or adenoid hypertrophy was found. In 43 cases a moderate monolateral or bilateral sensory-neural hearing loss at high frequencies with recruitment phenomenon was observed. Ferritin levels were determined in a randomly chosen group of these patients with (14) and without heaing loss (11). In the subjects with sensory-neural hearing loss the mean ferritin levels were significantly higher than in those with no hearing defect. There was no obvious relation between sensory-neural damage on the one hand and Hb levels and unit of blood transfused on the other. The results of this study suggest that iron overload could be a cause of damage in the high frequency elements of the auditory mechanism. Intermittent hypoxia and slow 8th nerve compression due to bony hypertrophy as causes of auditory involvement are also discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 108901     DOI: 10.1159/000207658

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

1.  Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine.

Authors:  V De Sanctis; A Pinamonti; A Di Palma; M Sprocati; G Atti; M R Gamberini; C Vullo
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

Review 2.  Deferoxamine (desferrioxamine). New toxicities for an old drug.

Authors:  Y Bentur; M McGuigan; G Koren
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

3.  Cerebral thrombosis in beta-thalassaemia major.

Authors:  M P Senanayake; S P Lamabadusuriya
Journal:  Indian J Pediatr       Date:  2001-11       Impact factor: 1.967

Review 4.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

5.  Multiple nerve palsies in beta thalassaemia major.

Authors:  S P Lamabadusuriya
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

6.  Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children.

Authors:  E A Llados i Vallory; R Girot; G Lenoir; M Payet; P Houze; R Bourdon
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

7.  Frequency of sensory neural hearing loss in major Beta-thalassemias in southern iran.

Authors:  Abolhassan Faramarzi; Mehran Karimi; Seyed-Taghi Heydari; Mahmoud Shishegar; Masoud Kaviani
Journal:  Iran J Pediatr       Date:  2010-09       Impact factor: 0.364

Review 8.  Hearing Loss in Beta-Thalassemia: Systematic Review.

Authors:  Immacolata Tartaglione; Roberta Carfora; Davide Brotto; Maria Rosaria Barillari; Giuseppe Costa; Silverio Perrotta; Renzo Manara
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.